Catalent Stock Return On Equity
Catalent fundamentals help investors to digest information that contributes to Catalent's financial success or failures. It also enables traders to predict the movement of Catalent Stock. The fundamental analysis module provides a way to measure Catalent's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Catalent stock.
Catalent |
Catalent Company Return On Equity Analysis
Catalent's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Catalent Return On Equity | -0.11 |
Most of Catalent's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Catalent is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Catalent has a Return On Equity of -0.1119. This is 99.53% lower than that of the Pharmaceuticals sector and significantly lower than that of the Health Care industry. The return on equity for all United States stocks is 63.9% lower than that of the firm.
Catalent Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Catalent's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Catalent could also be used in its relative valuation, which is a method of valuing Catalent by comparing valuation metrics of similar companies.Catalent is currently under evaluation in return on equity category among its peers.
Catalent Fundamentals
| Return On Equity | -0.11 | |||
| Return On Asset | -0.0018 | |||
| Profit Margin | (0.09) % | |||
| Operating Margin | (0.07) % | |||
| Current Valuation | 16.13 B | |||
| Shares Outstanding | 181.51 M | |||
| Shares Owned By Insiders | 0.50 % | |||
| Shares Owned By Institutions | 87.80 % | |||
| Number Of Shares Shorted | 14.74 M | |||
| Price To Earning | 17.80 X | |||
| Price To Book | 3.25 X | |||
| Price To Sales | 2.61 X | |||
| Revenue | 4.38 B | |||
| Gross Profit | 1.04 B | |||
| EBITDA | (284 M) | |||
| Net Income | (1.04 B) | |||
| Cash And Equivalents | 345 M | |||
| Cash Per Share | 1.92 X | |||
| Total Debt | 4.92 B | |||
| Debt To Equity | 0.90 % | |||
| Current Ratio | 2.86 X | |||
| Book Value Per Share | 19.52 X | |||
| Cash Flow From Operations | 268 M | |||
| Short Ratio | 7.89 X | |||
| Earnings Per Share | (2.28) X | |||
| Price To Earnings To Growth | 529.00 X | |||
| Target Price | 63.4 | |||
| Number Of Employees | 17 K | |||
| Beta | 1.16 | |||
| Market Capitalization | 11.52 B | |||
| Total Asset | 9.75 B | |||
| Retained Earnings | (781 M) | |||
| Working Capital | 1.57 B | |||
| Current Asset | 790.2 M | |||
| Current Liabilities | 391.2 M | |||
| Net Asset | 9.75 B |
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Catalent Stock
If you are still planning to invest in Catalent check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalent's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |